Related Experiment Video
Updated: Feb 6, 2026

Operation of the Collaborative Composite Manufacturing CCM System
Published on: October 1, 2019
Immunomodulatory activity of exopolysaccharide from the rhizobacterium Paenibacillus polymyxa CCM 1465
Irina V Yegorenkova1, Alla A Fomina2, Kristina V Tregubova3
1Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (IBPPM RAS), 13 Prospekt Entuziastov, Saratov, 410049, Russian Federation. egorenkova_i@ibppm.ru.
Abstract:
Bacterial polysaccharides are promising stimulants of protective functions in humans and animals. We investigated the ability of exopolysaccharide from the rhizobacterium Paenibacillus polymyxa CCM 1465 to induce nonspecific resistance factors in the macroorganism. We examined in vitro the effect of the exopolysaccharide, produced with different carbon sources, on the phagocytic activity of murine macrophages, on the generation of reactive oxygen species and of enzymes (acid phosphatase and myeloperoxidase), on the proliferation of murine splenocytes, and on the synthesis of proinflammatory cytokines [interleukin-1 (IL-1) and tumor necrosis factor α (TNF-α)] by human mononuclear cells. The exopolysaccharide promoted the phagocytosis of bacterial cells, activated metabolic processes in human and animal leukocytes, and moderately affected the production of TNF-α and IL-1β. The exopolysaccharides produced on media with glucose and sucrose differed in their effect on the immune cells, possibly owing to their different compositions, structures, and properties. The results validly indicate that the exopolysaccharide of P. polymyxa CCM 1465 promotes nonspecific immunity. Therefore, it can find application as a biologically active immunomodulatory substance.
Insights
Exopolysaccharide from Paenibacillus polymyxa CCM 1465 enhances nonspecific immunity by boosting immune cell activity. This bacterial polysaccharide shows potential as an immunomodulatory substance for promoting health.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Bacterial polysaccharides are recognized for their potential to stimulate protective immune responses in hosts.
- The exopolysaccharide (EPS) produced by Paenibacillus polymyxa CCM 1465 is a candidate for inducing nonspecific resistance.
- Understanding the immunomodulatory effects of bacterial EPS is crucial for developing novel therapeutic agents.
Purpose of the Study:
- To investigate the immunomodulatory potential of exopolysaccharide from Paenibacillus polymyxa CCM 1465.
- To evaluate the effect of EPS produced using different carbon sources on various immune cell functions.
- To determine the capacity of EPS to induce nonspecific resistance factors in a macroorganism.
Main Methods:
- In vitro analysis of murine macrophage phagocytic activity.
- Assessment of reactive oxygen species and enzyme generation (acid phosphatase, myeloperoxidase) in leukocytes.
- Measurement of murine splenocyte proliferation.
- Quantification of proinflammatory cytokine synthesis (IL-1β, TNF-α) by human mononuclear cells.
Main Results:
- The exopolysaccharide significantly promoted phagocytosis of bacterial cells by macrophages.
- Metabolic activity in human and animal leukocytes was enhanced by the exopolysaccharide.
- Moderate effects were observed on the production of tumor necrosis factor α (TNF-α) and interleukin-1β (IL-1β).
- Differences in immune cell responses were noted between exopolysaccharides produced on glucose versus sucrose media, suggesting variations in composition and structure.
Conclusions:
- Exopolysaccharide from Paenibacillus polymyxa CCM 1465 effectively promotes nonspecific immunity.
- The EPS demonstrates potential as a biologically active immunomodulatory substance.
- Variations in carbon sources during production can influence the immunomodulatory properties of the EPS.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Co-activators and Co-repressors
tRNA Activation
Activation Energy
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Secondary Active Transport

